Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.79 |
| ▸ | MEN1 | O00255 | 2/20 | 0.79 |
| ▸ | EGFR | P00533 | 1/20 | 0.79 |
| ▸ | SRC | P12931 | 1/20 | 0.79 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.79 |
| ▸ | CDK2 | P24941 | 1/20 | 0.79 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.79 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.79 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.79 |
| ▸ | RELA | Q04206 | 1/20 | 0.79 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.79 |
| ▸ | GUSB | P08236 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 3/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.71 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5512150 | 1.00 | CHRNA7 (0.81) | CHRNA7KMT2AMEN1EGFRSRC | |
| SCHEMBL634059 | 0.90 | CHRNA7 (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| SCHEMBL634060 | 0.90 | CHRNA7 (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL30383523 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL243647 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL25202104 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL29724857 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL139243 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL243646 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC | |
| Butein SCHEMBL505501 | 0.89 | KMT2A (1.00) | CHRNA7KMT2AMEN1EGFRSRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | claimed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | claimed |
| EP-1254658-B1 | REMEDIES FOR THE TREATMENT OF NERVE DIORDERS | TAKARA BIO INC (JP) | 2008-09-24 | — | — | EP | disclosed |
| US-7268160-B2 | Remedies | TAKARA BIO, INC. (JP) | 2007-09-11 | — | — | US | disclosed |
| US-20070092551-A1 | Therapeutic agent | TAKARA BIO INC. (JP) | 2007-04-26 | — | — | US | disclosed |
| EP-1623704-A1 | THERAPEUTIC AGENT | TAKARA BIO INC. (JP) | 2006-02-08 | — | — | EP | disclosed |
| US-20030144316-A1 | Remedies | TAKARA BIO INC. (JP) | 2003-07-31 | — | — | US | disclosed |
| EP-1254658-A1 | REMEDIES | TAKARA BIO INC. (JP) | 2002-11-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030144316-A1 | Remedies | NGF, BDNF, NTRK2 | CHRNA7 825/4885KMT2A 3404/4885MEN1 523/4885 |
| US-20070092551-A1 | Therapeutic agent | FABP4, GPR119, IAPP | CHRNA7 4487/4885KMT2A 4418/4885MEN1 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.